Clinical Trial Update: 68Ga-PSMA-R2 in Patients With Biochemical Relapse (BR) and Metastatic Prostate Cancer (mPCa) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updates for 68Ga-PSMA-R2 in biochemical relapse and metastatic prostate cancer completed Phase 1 and Phase 2 with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 68Ga-PSMA-R2 (68Ga-PSMA-R2)

Snippet

Sponsor: Advanced Accelerator Applications | Conditions: Prostate Cancer Metastatic | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-11-17